R1 RCM Inc. (RCM): Price and Financial Metrics

R1 RCM Inc. (RCM): $11.14

0.46 (+4.31%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

RCM Price/Volume Stats

Current price $11.14 52-week high $18.70
Prev. close $10.68 52-week low $8.87
Day low $10.56 Volume 4,465,000
Day high $11.35 Avg. volume 3,457,450
50-day MA $10.34 Dividend yield N/A
200-day MA $13.92 Market Cap 4.67B

RCM Stock Price Chart Interactive Chart >

RCM POWR Grades

  • RCM scores best on the Growth dimension, with a Growth rank ahead of 97.94% of US stocks.
  • RCM's strongest trending metric is Value; it's been moving up over the last 26 weeks.
  • RCM's current lowest rank is in the Sentiment metric (where it is better than 11.2% of US stocks).

RCM Stock Summary

  • The ratio of debt to operating expenses for R1 RCM INC is higher than it is for about 82.67% of US stocks.
  • Over the past twelve months, RCM has reported earnings growth of 65.5%, putting it ahead of 85.4% of US stocks in our set.
  • Revenue growth over the past 12 months for R1 RCM INC comes in at 32.28%, a number that bests 85.6% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to RCM, based on their financial statements, market capitalization, and price volatility, are SOVO, MTZ, ECPG, DNUT, and SKYW.
  • Visit RCM's SEC page to see the company's official filings. To visit the company's web site, go to www.r1rcm.com.

RCM Valuation Summary

  • In comparison to the median Healthcare stock, RCM's price/earnings ratio is 538.08% lower, now standing at -127.7.
  • Over the past 122 months, RCM's EV/EBIT ratio has gone up 60.7.

Below are key valuation metrics over time for RCM.

Stock Date P/S P/B P/E EV/EBIT
RCM 2023-12-29 2 1.6 -127.7 64.0
RCM 2023-12-28 2 1.6 -129.7 64.7
RCM 2023-12-27 2 1.6 -129.3 64.6
RCM 2023-12-26 2 1.6 -128.8 64.4
RCM 2023-12-22 2 1.6 -128.6 64.3
RCM 2023-12-21 2 1.6 -127.4 63.9

RCM Growth Metrics

    Its 2 year price growth rate is now at 87.54%.
  • Its year over year revenue growth rate is now at 17.39%.
  • The 2 year revenue growth rate now stands at 23.32%.
Over the past 34 months, RCM's revenue has gone up $575,700,000.

The table below shows RCM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 1,806.4 -9.9 -57.6
2022-09-30 1,672.5 6.5 15.5
2022-06-30 1,556.2 70.8 62
2022-03-31 1,517.7 249.7 100.8
2021-12-31 1,474.6 264.8 97.2
2021-09-30 1,404.1 230.1 139.8

RCM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RCM has a Quality Grade of C, ranking ahead of 32.75% of graded US stocks.
  • RCM's asset turnover comes in at 1.132 -- ranking 100th of 561 Business Services stocks.
  • ASGN, SNAP, and WIX are the stocks whose asset turnover ratios are most correlated with RCM.

The table below shows RCM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.132 0.194 0.159
2021-03-31 1.108 0.200 0.156
2020-12-31 1.135 0.196 0.160
2020-09-30 1.192 0.188 0.106
2020-06-30 1.278 0.195 0.134
2020-03-31 1.335 0.184 0.096

RCM Price Target

For more insight on analysts targets of RCM, see our RCM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $32.18 Average Broker Recommendation 1.35 (Strong Buy)

R1 RCM Inc. (RCM) Company Bio


R1 RCM Inc. provides revenue cycle management and physician advisory services for healthcare providers in the United States. It offers revenue cycle management services to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. The company also provides physician advisory services, which offer concurrent level of care billing classification reviews, as well as retrospective chart audits to assist hospitals in properly billing payers for selected services. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was founded in 2003 and is based in Chicago, Illinois.


RCM Latest News Stream


Event/Time News Detail
Loading, please wait...

RCM Latest Social Stream


Loading social stream, please wait...

View Full RCM Social Stream

Latest RCM News From Around the Web

Below are the latest news stories about R1 RCM INC that investors may wish to consider to help them evaluate RCM as an investment opportunity.

13 Most Promising Future Stocks To Buy According To Hedge Funds

In this piece, we will take a look at the 13 most promising stocks to buy according to hedge funds. If you want to skip our overview of the latest stock market news, then you can take a look at the 5 Most Promising Future Stocks To Buy. Investing, for the most part, is all […]

Yahoo | December 27, 2023

R1 RCM to Present at the 42nd Annual J.P. Morgan Healthcare Conference

MURRAY, Utah, Dec. 21, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2023, at 10:30am ET. A live audio webcast of each presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay of the

Yahoo | December 21, 2023

R1 RCM to Acquire Acclara

Acquisition of Providence’s Current Modular Services Business Accompanied by 10-Year Agreement to Provide Comprehensive Revenue Cycle Management Services R1 to Host Conference Call Today at 8:00 AM ET MURRAY, Utah, Dec. 06, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to acquire Acc

Yahoo | December 6, 2023

R1 Completes Restatement of Previously Issued Financial Statements

As Expected, No Material Impact on 2023 Financial Results; No Impact on Cash, Business Operations or 2023 OutlookMURRAY, Utah, Dec. 04, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”) (“Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has completed the restatement of its previously issued financial statements for the years ended December 31, 2022 and 2021 and int

Yahoo | December 4, 2023

R1 RCM Receives Notice of Filing Delinquency from Nasdaq

MURRAY, Utah, Nov. 17, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that, as anticipated, it received a letter from Nasdaq’s Listing Qualifications Department indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2023 (the “Form 10-Q”), the Compa

Yahoo | November 17, 2023

Read More 'RCM' Stories Here

RCM Price Returns

1-mo 6.60%
3-mo 2.86%
6-mo -31.78%
1-year -22.32%
3-year -60.16%
5-year 11.51%
YTD 5.39%
2023 -3.47%
2022 -57.04%
2021 6.12%
2020 85.05%
2019 63.27%

Continue Researching RCM

Want to see what other sources are saying about R1 Rcm Inc's financials and stock price? Try the links below:

R1 Rcm Inc (RCM) Stock Price | Nasdaq
R1 Rcm Inc (RCM) Stock Quote, History and News - Yahoo Finance
R1 Rcm Inc (RCM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!